Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Trainer

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumorsM Korbonits, R A Jacobs, S J Aylwin, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
The Journal of Clinical Endocrinology and Metabolism|October 13, 1998
Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumorsM Korbonits, R A Jacobs, S J Aylwin, et al.
Lancet (London, England)|December 6, 2001
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistA J van der Lely, R K Hutson, P J Trainer, et al.
The New England Journal of Medicine|April 20, 2000
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomantP J Trainer, W M Drake, L Katznelson, et al.
Pageof 11